203 related articles for article (PubMed ID: 18393288)
61. BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.
Pan XB; Qu XW; Jiang D; Zhao XL; Han JC; Wei L
Antiviral Res; 2013 Apr; 98(1):54-60. PubMed ID: 23422647
[TBL] [Abstract][Full Text] [Related]
62. Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of cyclooxygenase-2 expression.
Lin CK; Tseng CK; Liaw CC; Huang CY; Wei CK; Sheu JH; Lee JC
Sci Rep; 2018 Jun; 8(1):8676. PubMed ID: 29875371
[TBL] [Abstract][Full Text] [Related]
63. Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity.
Madejón A; Sheldon J; Francisco-Recuero I; Perales C; Domínguez-Beato M; Lasa M; Sánchez-Perez I; Muntané J; Domingo E; García-Samaniego J; Sánchez-Pacheco A
J Hepatol; 2015 Aug; 63(2):312-9. PubMed ID: 25733156
[TBL] [Abstract][Full Text] [Related]
64. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.
Nakagawa S; Umehara T; Matsuda C; Kuge S; Sudoh M; Kohara M
Biochem Biophys Res Commun; 2007 Feb; 353(4):882-8. PubMed ID: 17196931
[TBL] [Abstract][Full Text] [Related]
65. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening.
Supekova L; Supek F; Lee J; Chen S; Gray N; Pezacki JP; Schlapbach A; Schultz PG
J Biol Chem; 2008 Jan; 283(1):29-36. PubMed ID: 17951261
[TBL] [Abstract][Full Text] [Related]
66. Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway.
Pei R; Zhang X; Xu S; Meng Z; Roggendorf M; Lu M; Chen X
Virol Sin; 2012 Oct; 27(5):278-85. PubMed ID: 23001481
[TBL] [Abstract][Full Text] [Related]
67. Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade.
Huang Y; Chen XC; Konduri M; Fomina N; Lu J; Jin L; Kolykhalov A; Tan SL
Hepatology; 2006 Jan; 43(1):81-90. PubMed ID: 16374867
[TBL] [Abstract][Full Text] [Related]
68. A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
Ulitzky L; Lafer MM; KuKuruga MA; Silberstein E; Cehan N; Taylor DR
PLoS One; 2016; 11(1):e0145212. PubMed ID: 26731262
[TBL] [Abstract][Full Text] [Related]
69. Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation.
Chen KJ; Tseng CK; Chang FR; Yang JI; Yeh CC; Chen WC; Wu SF; Chang HW; Lee JC
PLoS One; 2013; 8(2):e57704. PubMed ID: 23469054
[TBL] [Abstract][Full Text] [Related]
70. Interference of hepatitis C virus RNA replication by short interfering RNAs.
Kapadia SB; Brideau-Andersen A; Chisari FV
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2014-8. PubMed ID: 12566571
[TBL] [Abstract][Full Text] [Related]
71. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
[TBL] [Abstract][Full Text] [Related]
72. Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes.
Subramanian N; Mani P; Roy S; Gnanasundram SV; Sarkar DP; Das S
J Gen Virol; 2009 Aug; 90(Pt 8):1812-1819. PubMed ID: 19297606
[TBL] [Abstract][Full Text] [Related]
73. Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation.
Liao CL; Lin YL; Wu BC; Tsao CH; Wang MC; Liu CI; Huang YL; Chen JH; Wang JP; Chen LK
J Virol; 2001 Sep; 75(17):7828-39. PubMed ID: 11483726
[TBL] [Abstract][Full Text] [Related]
74. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.
Lee MY; Chen WC; Hsu WH; Chen SC; Lee JC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540136
[TBL] [Abstract][Full Text] [Related]
75. Cloning and expression of retinoic acid-induced gene-I and its effect on hepatitis C virus replication.
Shen Y; Qian Y; Shen L; Wu Z; Xu C; Tong X
Lab Med; 2014; 45(2):103-10. PubMed ID: 24868989
[TBL] [Abstract][Full Text] [Related]
76. Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.
Myskiw C; Deschambault Y; Jefferies K; He R; Cao J
J Virol; 2007 Mar; 81(6):3027-32. PubMed ID: 17192307
[TBL] [Abstract][Full Text] [Related]
77. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
[TBL] [Abstract][Full Text] [Related]
78. Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.
Choi SS; Bradrick S; Qiang G; Mostafavi A; Chaturvedi G; Weinman SA; Diehl AM; Jhaveri R
Hepatology; 2011 Nov; 54(5):1580-90. PubMed ID: 21793033
[TBL] [Abstract][Full Text] [Related]
79. Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
Choi JE; Kwon JH; Kim JH; Hur W; Sung PS; Choi SW; Yoon SK
PLoS One; 2015; 10(3):e0119172. PubMed ID: 25798824
[TBL] [Abstract][Full Text] [Related]
80. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways.
Lu L; Wei L; Peng G; Mu Y; Wu K; Kang L; Yan X; Zhu Y; Wu J
Virology; 2008 Feb; 371(1):61-70. PubMed ID: 17964630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
